Inventor · disambiguated record
Christian Carsten Silvester Kunz
Also filed as: KUNZ CHRISTIAN · KUNZ CHRISTIAN CARSTEN SILVESTER · Kunz Christian Carsten Silverster
12 granted patents·8 pending applications·91 citations·filing 2011–2025
89Inventor score
Top patents by PatentIndex Score
20 records- 0192US9376489B2IL-18 binding moleculesBARDROFF MICHAEL OTTO·Filed 2013·Granted Jun 28, 2016·14 cites·25 claims
- 0291US8735551B2Antibodies for epidermal growth factor receptor 3 (HER3)GARNER ANDREW PAUL·Filed 2011·Granted May 27, 2014·43 cites·31 claims
- 0390US9051365B2Antibodies that bind factor PNOVARTIS AG·Filed 2012·Granted Jun 9, 2015·18 cites·11 claims
- 0487US2025034240A1Il-18 binding moleculesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0584US9192663B2Antibodies for epidermal growth factor receptor 3 (HER3)NOVARTIS AG·Filed 2012·Granted Nov 24, 2015·8 cites·8 claims
- 0683US11111293B2IL-18 binding moleculesNOVARTIS AG·Filed 2018·Granted Sep 7, 2021·1 cites·15 claims
- 0778US10077317B2Antibodies for epidermal growth factor receptor 3 (HER3)NOVARTIS AG·Filed 2014·Granted Sep 18, 2018·3 cites·3 claims
- 0876US11779649B2Antibodies to PMEL17 and conjugates thereofNOVARTIS AG·Filed 2019·Granted Oct 10, 2023·1 cites·55 claims
- 0976US10081677B2IL-18 binding moleculesBARDROFF MICHAEL OTTO·Filed 2016·Granted Sep 25, 2018·1 cites·6 claims
- 1076US2024189439A1Antibodies to pmel17 and conjugates thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1176US2022098296A1Il-18 binding moleculesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1274US9988440B2Compositions comprising antibodies targeting factor PNOVARTIS AG·Filed 2014·Granted Jun 5, 2018·2 cites·33 claims
- 1365US12304958B2Antibodies targeting ActRIIA and ActRIIBSIXPEAKS BIO AG·Filed 2024·Granted May 20, 2025·0 cites·14 claims
- 1464US10865237B2Nucleic acids encoding anti-Factor P antibodiesNOVARTIS AG·Filed 2018·Granted Dec 15, 2020·0 cites·11 claims
- 1564US2021008201A1Antibodies for epidermal growth factor receptor 3 (her3)NOVARTIS AG·Filed 2020·Application pending·0 cites
- 1657US2019216924A1Antibodies for epidermal growth factor receptor 3 (her3)NOVARTIS AG·Filed 2018·Application pending·0 cites
- 1755US2019194347A1Antibodies for epidermal growth factor receptor 3 (her3)NOVARTIS AG·Filed 2018·Application pending·0 cites
- 1849US10080800B2Antibodies for epidermal growth factor receptor 3 (HER3)NOVARTIS AG·Filed 2015·Granted Sep 25, 2018·0 cites·9 claims
- 1948US2025243286A1Antibodies Targeting ActRIIA and ActRIIBSIXPEAKS BIO AG·Filed 2025·Application pending·0 cites
- 2040US2013273029A1Antibodies for epidermal growth factor receptor 3 (her3) directed to domain ii of her3NOVARTIS AG·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →